BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17703783)

  • 1. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q; Hou SX; Zhang X; Zhao G; Gou XJ; You JZ
    Yao Xue Xue Bao; 2007 May; 42(5):557-61. PubMed ID: 17703783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
    Zhu L; Ma J; Jia N; Zhao Y; Shen H
    Colloids Surf B Biointerfaces; 2009 Jan; 68(1):1-6. PubMed ID: 19013060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
    Grenha A; Remuñán-López C; Carvalho EL; Seijo B
    Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
    Mi FL; Wu YY; Chiu YL; Chen MC; Sung HW; Yu SH; Shyu SS; Huang MF
    Biomacromolecules; 2007 Mar; 8(3):892-8. PubMed ID: 17316043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and antibacterial activity of compound chitosan-compound Yizhihao-nanoparticles.
    Ou S; Zhang YD
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):369-74. PubMed ID: 18544838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
    Diebold Y; Jarrín M; Sáez V; Carvalho EL; Orea M; Calonge M; Seijo B; Alonso MJ
    Biomaterials; 2007 Mar; 28(8):1553-64. PubMed ID: 17169422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J; Chen XG; Peng WB; Liu CS
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
    Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
    Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
    Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
    Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
    Yang XR; Zong L; Yuan XY
    Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
    Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
    Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspension of Fe(3)O(4) nanoparticles stabilized by chitosan and o-carboxymethylchitosan.
    Zhu A; Yuan L; Liao T
    Int J Pharm; 2008 Feb; 350(1-2):361-8. PubMed ID: 17931808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.
    Grenha A; Grainger CI; Dailey LA; Seijo B; Martin GP; Remuñán-López C; Forbes B
    Eur J Pharm Sci; 2007 Jun; 31(2):73-84. PubMed ID: 17408932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C; Chen D; Gu J; Qin J
    J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro.
    Yang X; Zhang Q; Wang Y; Chen H; Zhang H; Gao F; Liu L
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):125-31. PubMed ID: 17869489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X; Chi N; Tang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.